MENU

VRTX Vertex Pharmaceuticals Chart, History Price & Graph

a company that discovers and develops novel, small molecule pharmaceuticals

Industry: #Biotechnology
VRTX
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days

Vertex Pharmaceuticals (VRTX) Price Chart Analysis: Trend, Key Levels, and Technical Signals

Key Takeaways

  • Vertex Pharmaceuticals (VRTX) is in a short-term downtrend, trading below key moving averages including the 50-day at 431.18 and 200-day at 440.11.
  • Moving averages indicate a strong sell with 11 sell signals out of 12.
  • RSI (14) at 47.15 shows neutral momentum, while MACD (12,26) at -0.77 signals bearish divergence.
  • Key support near 427.60-426.71, resistance at 429.81-431.36 based on pivot points.
  • Recent price action reflects consolidation and pullback after breaking an ascending channel, with targets around 403-404 discussed by traders.

Price Action and Trend Overview

Vertex Pharmaceuticals (VRTX) shares have exhibited a corrective phase in recent trading, pulling back from higher levels within a broader uptrend context. The stock recently broke below an ascending channel and retested it as resistance, signaling potential weakness. Over the last 30 days, VRTX has traded in a choppy range, declining toward the mid-420s amid reduced momentum. This price action suggests a shift to sideways-to-bearish behavior, with the 52-week range spanning 362.50 to 509.00 highlighting significant volatility but current positioning in the lower half.

Moving Averages Analysis

The moving averages paint a bearish picture for VRTX. The stock trades below its 5-day simple moving average at 428.88, 20-day at 427.31, 50-day at 431.18, 100-day at 435.38, and 200-day at 440.11. Exponential averages reinforce this, with the 50-day EMA at 430.60 and 200-day EMA at 441.59 also above current levels. This alignment indicates downward pressure, as only the 10-day simple MA at 427.14 offers minor support nearby. The strong sell summary from moving averages underscores a lack of bullish crossover potential in the near term.

Momentum Indicators

Momentum indicators present a mixed but leaning bearish view. The RSI (14) at 47.151 remains neutral, neither overbought nor oversold, allowing for potential stabilization. However, the MACD (12,26) level at -0.77 confirms selling pressure with a bearish signal. Stochastic (9,6) at 78.506 suggests buy potential from oversold conditions, while ADX (14) at 37.346 indicates a strong trend in play, albeit downward. Williams %R at -34.007 adds to buy hints near -20 oversold threshold, but overall indicators balance to neutral.

Support and Resistance Levels

Pivot points highlight immediate levels for VRTX: support at S1 428.26, S2 427.60, and S3 426.71, with resistance at R1 429.81, R2 430.70, and R3 431.36. The pivot point sits at 429.15. Broader trader discussions point to channel breakdown targets near 403-404 as potential deeper support, while near-term resistance aligns with the 50-day MA at 431.18. These zones represent supply and demand areas where price has previously reacted.

Tickeron’s AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for VRTX and other stocks and ETFs. These signals identify potential buy or sell opportunities by recognizing trends, momentum shifts, and recurring chart formations that have proven reliable over time. Traders rely on them to pinpoint entry and exit points, validate ongoing trends, and enhance decision-making processes amid volatile conditions. The AI models continuously adapt to new data, providing objective insights independent of human bias. To integrate these powerful tools into your analysis, explore the AI Daily Buy/Sell Signals for real-time guidance on VRTX.

Technical Outlook and Key Levels to Watch

Traders are monitoring VRTX for a potential hold at pivot supports around 427-426, where buyers could defend against further downside. A break below 426.71 may accelerate toward channel lows near 404, testing deeper liquidity. Conversely, reclaiming 429.81 and the pivot at 429.15 could signal stabilization toward 431 resistance and the 50-day MA. Key indicators like MACD crossover and RSI divergence above 50 will be critical for trend shifts. Volume confirmation on any breakout remains essential in this corrective phase.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

View a ticker or compare two or three
VRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

VRTX and Stocks

Correlation & Price change

A.I.dvisor tells us that VRTX and CRSP have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VRTX and CRSP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-1.60%
CRSP - VRTX
32%
Poorly correlated
+1.88%
EDIT - VRTX
31%
Poorly correlated
+5.49%
LRMR - VRTX
31%
Poorly correlated
+2.82%
ACET - VRTX
30%
Poorly correlated
N/A
TRDA - VRTX
30%
Poorly correlated
+4.11%
More
Vertex Pharmaceuticals (VRTX) Price Chart Analysis: Trend, Key Levels, and Technical Signals